ARTICLES BY THIS AUTHOR
- 7/5/2023
Edgewell Personal Care releases 2022 Sustainability Report
Edgewell has made progress from the previous fiscal year across its brands, supply chain, operations, people and communities. - 7/5/2023
CellTrans obtains FDA OK for Lantidra
Lantidra is the first cellular therapy to treat patients with Type 1 diabetes. - 7/5/2023
CHPA responds to FDA proposal for a Unified Human Foods program
CHPA also requested a meeting with FDA’s leadership to ensure the proposed organization structure would not dilute the prioritization of dietary supplements. - 7/5/2023
Albertsons’ O Organics launches Fight Hunger, Serve Hope Cause program
For every O Organics product purchased in July, the company will donate a nutritious meal to a child in need. - 7/5/2023
NACDS kicks off registration for 2024 annual meeting
The NACDS annual meeting will take place April 27-30, 2024, at The Breakers in Palm Beach, Fla. - 7/5/2023
Lupin launches generic Banzel
Generic Banzel is used for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children aged 4 years old and older and adults. - 7/3/2023
Placer.ai sizes up how retailers, CPG companies can cater to brick-and-mortar shoppers
Retailers that leverage up-to-date and in-depth insights on in-store habits can tailor their strategies to best service today’s customers. - 7/3/2023
Del Monte Foods releases survey highlighting snacking behaviors
A new survey from Del Monte Foods reveals new insights into snacking habits. - 7/3/2023
AAM releases drug shortage white paper
AAM said in its white paper that recent reports suggest a rise in shortages in 2023. - 7/3/2023
Aurobindo receives FDA OK for generic Banzel
Rufinamide tablets are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older, and in adults.